A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia

NCT06859073 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Hyperuricemia

Interventions

DRUG: NNC4004-0002
DRUG: Placebo

Sponsor

Novo Nordisk A/S